Biotechnology | Cloning | CRISPR | Environmental | Genomics
Colossal Biosciences announces de-extinction of dire wolf
On Apr. 7, 2025, scientists at Colossal Biosciences announced the successful de-extinction of the dire wolf with the…
-
-
Europe steps up recruitment of U.S. scientists
On April 3, France’s Université Paris-Saclay said it is one of dozens of European institutions ramping up efforts…
-
Biotechnology | CRISPR | Disease | Genomics | Oncology | Therapeutics
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Scientists from Colossal Biosciences genetically engineer mice with extinct woolly mammoth
On Mar. 4, 2025, Colossal Biosciences announced that its scientists have simultaneously edited seven genes in mice embryos…
-
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Genomics | Infectious Disease | Influenza | Medical Device | NIH | Oncology | Therapeutics | Vaccine
U.S. Implements New Export Controls to Address National Security Risks Related to Biotechnology
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
-
New CRISPR Toolkit to Allow Remote-Controlled Genome Editing
On Dec. 2, 2024, engineers in the University of Southern California (USC) Alfred E. Mann Department of Biomedical…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden is zeroing in on the policy goals closest to his heart…
-
Biotechnology | CRISPR | Genomics | USDA
USDA-APHIS Determined Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the U.S.
On Mar. 27, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
-
Artificial Intelligence | Biotechnology | Cloning | CRISPR | Forestry | Genomics | Imaging | Infectious Disease | Marine Science | Medical Device | Medicine | Nutraceuticals | Oncology | Pharmaceutical | Quantum | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine
National Science Board published “The State of U.S. Science and Engineering 2024”
On Mar. 13, 2024, the National Science Board (NSB) published The State of U.S. Science and Engineering 2024,…
-
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
-
Biotechnology | CRISPR | Disease | FDA | Therapeutics
CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemia
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
-
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
-
CRISPR | FDA | Genomics | Stem Cell | Therapeutics
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
-
Biotechnology | CRISPR | FDA | Genomics | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
-
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
-
COVID-19 | CRISPR | Therapeutics | Vaccine
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
-
FDA Approved First University-made Sausage from Gene-edited Pigs
On May 3, 2023, Washington State University (WSU) made history in the United States (US) by becoming the…
-
Biotechnology | CRISPR | Diagnostics | Disease | Genomics | Therapeutics
Jennifer Doudna and Jill Banfield to lead $70 million initiative to edit the microbiome
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
-
Agriculture | Biotechnology | Cartoons - Original | COVID-19 | CRISPR | Diagnostics | Disease | FDA | Genomics | Life Science History | Therapeutics | USDA
Milestones in CRISPR
The Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
-
Biotechnology | CRISPR | Disease | Prehistory | Therapeutics
2.6 billion-year-old ancestors of the CRISPR gene-editing tool resurrected
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Medicine | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
-
Agriculture | Biotechnology | CRISPR | Genomics | USDA
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…
-
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Cancer MoonShot program reignited
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Evolution of CRISPR
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
-
Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technology
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
-
Mammoth Biosciences and Agilent partnered on high-throughput CRISPR-based SARS-CoV-2 diagnostic test
On Jan 28, 2021, Mammoth Biosciences announced a co-marketing agreement with Agilent Technologies to support the anticipated launch…
-
Mammoth Biosciences secured U.S. DoD award to develop CRISPR-based diagnostics and biosurveillance platforms
On Jan. 14, 2021, Mammoth Biosciences announced that it had secured a subcontract with MRIGlobal, the prime contractor…
-
Biotechnology | CRISPR | FDA | Therapeutics
FDA cleared initiation of the Editas Medicine’s EDIT-301 clinical trial using CRISPR/Cas12a gene editing
On Jan. 11, 2021, Editas Medicine announced the U.S. Food and Drug Administration (FDA) had cleared the initiation…
-
Biotechnology | CRISPR | FDA | Therapeutics
CIRM-funded project targeting sickle cell disease received green light for clinical trial
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
